ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,783.00
-0.71%
S&P ASX All Technology
3,113.80
0.20%
Brent Oil
84.34
0.18%
US Dollar vs AUD
1.50138
-0.24%
Bitcoin
61,453.50
-0.58%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ocuphire Pharma Inc (OCUP)

  7. Ocuphire Pharma Inc (OCUP) News

OCUP

Ocuphire Pharma (OCUP)

Ocuphire Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OCUP
DateTimeSourceHeadlineSymbolCompany
14/06/202407:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/06/202407:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/06/202407:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/06/202407:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/06/202407:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/06/202407:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
14/06/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
25/05/202406:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
22/05/202406:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
11/05/202406:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCUPOcuphire Pharma Inc
11/05/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
10/05/202422:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
09/03/202409:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OCUPOcuphire Pharma Inc
09/03/202400:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
17/02/202408:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCUPOcuphire Pharma Inc
17/02/202408:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
15/02/202410:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
15/02/202410:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
15/02/202410:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
15/02/202410:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
24/01/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCUPOcuphire Pharma Inc
23/01/202410:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
23/01/202410:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
13/01/202408:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
13/01/202408:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
13/01/202408:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
12/01/202408:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OCUPOcuphire Pharma Inc
11/01/202409:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCUPOcuphire Pharma Inc
04/01/202410:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
04/01/202410:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:OCUP

Your Recent History

ASX
TLS
Telstra
FX
GBPAUD
Sterling vs AUD
NYSE
MRK
Merck
NYSE
NKE
Nike
ASX
WPL
Woodside Petroleum
NASDAQ
GOOGL
Alphabet
FX
AUDUSD
AUD vs US Dollar
ASX
RIO
Rio Tinto
ASX
NAB
National Australia Bank
NYSE
KO
Coca Cola
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
ASX
AMP
AMP
FX
AUDJPY
AUD vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved